Orixone TZ 500mg/62.5mg Injection
Marketer
Otik Biotec
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Orixone TZ 500mg/62.5mg Injection
The dual-action injectable medication, Orixone TZ 500mg/62.5mg, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under a doctor's guidance; strictly adhere to the prescribed schedule and complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and indigestion; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, breathlessness). Inform your physician of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and ample hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor the treatment's effects.
Primary Ingredients of Orixone TZ 500mg/62.5mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Orixone TZ 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Orixone TZ 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Orixone TZ 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Orixone TZ 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Orixone TZ 500mg/62.5mg Injection works:
Ceftriaxone and Tazobactum, combined as Orixone TZ 500mg/62.5mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Orixone TZ 500mg/62.5mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Orixone TZ, 500mg/62.5mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to developing offspring; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Orixone TZ 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Orixone TZ 500mg/62.5mg Injection might cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Orixone TZ 500mg/62.5mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Orixone TZ 500mg/62.5mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the dose of Orixone TZ 500mg/62.5mg Injection is generally not suggested for those with mild or moderately compromised liver function.
What if you forget to take Orixone TZ 500mg/62.5mg Injection :
Should you forget a dose of the Orixone TZ 500mg/62.5mg Injection, seek medical advice.
Facts to Know About Orixone TZ 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infectives |
3,018 People bought this recently